• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

OtherGlobal Infectious Disease Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • RnM2414280
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 116 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.

Scope of the Report:

This report studies the Infectious Disease Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Infectious Disease Therapeutics market by product type and applications/end industries.

Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of infectious diseases, escalating consumption of anti-microbial direct acting drugs, growing geriatric population, rising awareness among population, upsurge in government investment into healthcare to eradicate infectious diseases.

The global Infectious Disease Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Infectious Disease Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Novartis AG

Gilead

GlaxoSmithKline plc

Janssen Pharmaceutical Inc.

F. Hoffmann-La Roche Ltd.

BioCryst Pharmaceuticals Inc.

Merck & Co. Inc.

Boehringer Ingelheim GmbH

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Drugs

Vaccines

Market Segment by Applications, can be divided into

HIV/AIDS

Influenza

Hepatitis

Malaria

Tuberculosis

Others


Table of Contents

1 Infectious Disease Therapeutics Market Overview

1.1 Product Overview and Scope of Infectious Disease Therapeutics

1.2 Classification of Infectious Disease Therapeutics by Types

1.2.1 Global Infectious Disease Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Infectious Disease Therapeutics Revenue Market Share by Types in 2017

1.2.3 Drugs

1.2.4 Vaccines

1.3 Global Infectious Disease Therapeutics Market by Application

1.3.1 Global Infectious Disease Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 HIV/AIDS

1.3.3 Influenza

1.3.4 Hepatitis

1.3.5 Malaria

1.3.6 Tuberculosis

1.3.7 Others

1.4 Global Infectious Disease Therapeutics Market by Regions

1.4.1 Global Infectious Disease Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Infectious Disease Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Infectious Disease Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infectious Disease Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Infectious Disease Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infectious Disease Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Infectious Disease Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 Novartis AG

2.1.1 Business Overview

2.1.2 Infectious Disease Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Novartis AG Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Gilead

2.2.1 Business Overview

2.2.2 Infectious Disease Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Gilead Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 GlaxoSmithKline plc

2.3.1 Business Overview

2.3.2 Infectious Disease Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Janssen Pharmaceutical Inc.

2.4.1 Business Overview

2.4.2 Infectious Disease Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.5 F. Hoffmann-La Roche Ltd.

2.5.1 Business Overview

2.5.2 Infectious Disease Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.6 BioCryst Pharmaceuticals Inc.

2.6.1 Business Overview

2.6.2 Infectious Disease Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck & Co. Inc.

2.7.1 Business Overview

2.7.2 Infectious Disease Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.8 Boehringer Ingelheim GmbH

2.8.1 Business Overview

2.8.2 Infectious Disease Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Infectious Disease Therapeutics Market Competition, by Players

3.1 Global Infectious Disease Therapeutics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Infectious Disease Therapeutics Players Market Share

3.2.2 Top 10 Infectious Disease Therapeutics Players Market Share

3.3 Market Competition Trend

4 Global Infectious Disease Therapeutics Market Size by Regions

4.1 Global Infectious Disease Therapeutics Revenue and Market Share by Regions

4.2 North America Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

4.3 Europe Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

4.5 South America Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Infectious Disease Therapeutics Revenue by Countries

5.1 North America Infectious Disease Therapeutics Revenue by Countries (2013-2018)

5.2 USA Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

5.3 Canada Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

5.4 Mexico Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Infectious Disease Therapeutics Revenue by Countries

6.1 Europe Infectious Disease Therapeutics Revenue by Countries (2013-2018)

6.2 Germany Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

6.3 UK Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

6.4 France Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

6.5 Russia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

6.6 Italy Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Infectious Disease Therapeutics Revenue by Countries

7.1 Asia-Pacific Infectious Disease Therapeutics Revenue by Countries (2013-2018)

7.2 China Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

7.3 Japan Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

7.4 Korea Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

7.5 India Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Infectious Disease Therapeutics Revenue by Countries

8.1 South America Infectious Disease Therapeutics Revenue by Countries (2013-2018)

8.2 Brazil Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

8.3 Argentina Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

8.4 Colombia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Infectious Disease Therapeutics by Countries

9.1 Middle East and Africa Infectious Disease Therapeutics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

9.3 UAE Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

9.4 Egypt Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

9.6 South Africa Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Infectious Disease Therapeutics Market Segment by Type

10.1 Global Infectious Disease Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Global Infectious Disease Therapeutics Market Forecast by Type (2018-2023)

10.3 Drugs Revenue Growth Rate (2013-2023)

10.4 Vaccines Revenue Growth Rate (2013-2023)

11 Global Infectious Disease Therapeutics Market Segment by Application

11.1 Global Infectious Disease Therapeutics Revenue Market Share by Application (2013-2018)

11.2 Infectious Disease Therapeutics Market Forecast by Application (2018-2023)

11.3 HIV/AIDS Revenue Growth (2013-2018)

11.4 Influenza Revenue Growth (2013-2018)

11.5 Hepatitis Revenue Growth (2013-2018)

11.6 Malaria Revenue Growth (2013-2018)

11.7 Tuberculosis Revenue Growth (2013-2018)

11.8 Others Revenue Growth (2013-2018)

12 Global Infectious Disease Therapeutics Market Size Forecast (2018-2023)

12.1 Global Infectious Disease Therapeutics Market Size Forecast (2018-2023)

12.2 Global Infectious Disease Therapeutics Market Forecast by Regions (2018-2023)

12.3 North America Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)

12.4 Europe Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)

12.6 South America Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Infectious Disease Therapeutics . Industry analysis & Market Report on Infectious Disease Therapeutics is a syndicated market report, published as Global Infectious Disease Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Infectious Disease Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,480.00
$5,220.00
$6,960.00
2,336.82
3,505.23
4,673.64
3,202.30
4,803.44
6,404.59
421,567.20
632,350.80
843,134.40
230,770.63
346,155.95
461,541.26
Add To Cart Credit card Logo

Related Reports


Reason to Buy